Fundies.
English

Segment disclosures

Company overview

C4 Therapeutics, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 12 retained observations 7 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cccc:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260811Open filing evidence
2026-01-01 – 2026-06-300 USD20260811Open filing evidence
2026-01-01 – 2026-03-310 USD20260512Open filing evidence
2025-07-01 – 2025-09-300 USD20251106Open filing evidence
2025-01-01 – 2025-09-300 USD20251106Open filing evidence
2025-04-01 – 2025-06-300 USD20260811Open filing evidence
2025-01-01 – 2025-06-300 USD20260811Open filing evidence
2025-01-01 – 2025-03-310 USD20260512Open filing evidence
2024-07-01 – 2024-09-300 USD20251106Open filing evidence
2024-01-01 – 2024-09-300 USD20251106Open filing evidence
2024-04-01 – 2024-06-300 USD20250807Open filing evidence
2024-01-01 – 2024-06-300 USD20250807Open filing evidence